Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Array BioPharma Inc
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 AstraZeneca Plc
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 Daiichi Sankyo Company Ltd
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Handok Inc
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 Ignyta Inc
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Loxo Oncology Inc
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 Netris Pharma SAS
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 Plexxikon Inc
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Breast Cancer
  • 4.1.1 Overview
  • 4.1.2 Breast Cancer Market Size and Forecast
• 4.2 Brain Cancer
  • 4.2.1 Overview
  • 4.2.2 Brain Cancer Market Size and Forecast
• 4.3 Solid Tumor
  • 4.3.1 Overview
  • 4.3.2 Solid Tumor Market Size and Forecast
• 4.4 Colon Cancer
  • 4.4.1 Overview
  • 4.4.2 Colon Cancer Market Size and Forecast
• 4.5 Fibrosarcoma
  • 4.5.1 Overview
  • 4.5.2 Fibrosarcoma Market Size and Forecast
• 4.6 Others
  • 4.6.1 Overview
  • 4.6.2 Others Market Size and Forecast

5 Market by Type

5.By AZD-7451

• 5.1 AZD-7451
  • 5.1.1 Overview
  • 5.1.2 AZD-7451 Market Size and Forecast
• 5.2 Larotrectinib
  • 5.2.1 Overview
  • 5.2.2 Larotrectinib Market Size and Forecast
• 5.3 DS-6051
  • 5.3.1 Overview
  • 5.3.2 DS-6051 Market Size and Forecast
• 5.4 LM-22B10
  • 5.4.1 Overview
  • 5.4.2 LM-22B10 Market Size and Forecast
• 5.5 Others
  • 5.5.1 Overview
  • 5.5.2 Others Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion

Summary
The global NT 3 Growth Factor Receptor market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Array BioPharma Inc
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Netris Pharma SAS
Plexxikon Inc
Major applications as follows:
Breast Cancer
Brain Cancer
Solid Tumor
Colon Cancer
Fibrosarcoma
Others
Major Type as follows:
AZD-7451
Larotrectinib
DS-6051
LM-22B10
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa